NCT02846701View on ClinicalTrials.gov

Determination of the Antidepressant Duloxetine in Plasma to Improve the Knowledge of the Analgesic Action of Antidepressants on Chronic Neuropathic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 17, 2016

Primary Completion Date

June 20, 2017

Study Completion Date

June 16, 2019

Conditions
Neuropathic Pain
Interventions
DRUG

duloxetine

The concentration of duloxetine is measured by liquid chromatography coupled to tandem mass spectrometry on blood sample

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT02846701 - Determination of the Antidepressant Duloxetine in Plasma to Improve the Knowledge of the Analgesic Action of Antidepressants on Chronic Neuropathic Pain | Biotech Hunter | Biotech Hunter